Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

Completed

Conditions studied: Haemostasis, Congenital Bleeding Disorder, Haemophilia B

In brief

This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).

Key facts

Study ID

NCT02568202

Run by

Novo Nordisk A/S

People needed

449

Starts

2015-09-01

Expected to finish

2015-11-01

Last updated by the study team

2016-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged below or equal to 18 years with hemophilia B (any severity, with or without inhibitors)
• Caregivers of children currently aged below 18 years with hemophilia B (any severity, with or without inhibitors)
• Subjects must have access to the internet, either at home or at a location convenient to them
• Provision of informed consent before the start of any survey-related activities

You may not qualify if…

• Inability to understand and comply with written instructions in English
• Previous completion of the B-HERO-S study with receipt of compensation
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Where it is running

• Novo Nordisk Clinical Trial Call Center — Plainsboro, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.